Lemonade (LMND) has extended its renters insurance offering to Montana, giving the stock a fresh product expansion angle that investors can weigh against recent share performance and the company’s broader insurance footprint.

The Montana launch comes as Lemonade’s share price has risen 9.02% over the past month but is still down 22.54% year to date, while the 1 year and 3 year total shareholder returns of 45.28% and over 200% highlight how sentiment has swung over time.

If this kind of product expansion has you thinking about where else growth stories might emerge, it could be worth scanning 20 top founder-led companies

With Lemonade’s shares up over the past month but still down for the year, and the stock trading only slightly below the latest analyst price target, investors now have to ask: Is there real upside left, or is future growth already priced in?

Most Popular Narrative: 9.6% Undervalued

With Lemonade shares last closing at $58.84 against a most-followed narrative fair value of $65.11, the current price sits below that narrative anchor, leaving investors to weigh how the story behind that gap holds up.

The current valuation may be factoring in Lemonade's perceived AI advantage and operational efficiency. However, intensifying competition from both insurtech startups and digitalizing incumbents could erode pricing power and customer retention, limiting both revenue growth and future profitability.

Want to see what is baked into that fair value for Lemonade? The narrative leans heavily on rapid revenue compounding, widening margins and a rich future earnings multiple. Curious how those moving parts fit together into one price tag?

Result: Fair Value of $65.11 (UNDERVALUED)

However, Lemonade’s narrative could shift if higher claim volatility or tougher AI and data regulation raise costs faster than its automation and expansion efforts can offset.

Another View: How Lemonade Looks On Sales Based Valuation

Narrative driven fair value estimates currently suggest that Lemonade is 9.6% undervalued, but the current P/S of 5.4x presents a tougher picture. That multiple is well above the US Insurance industry average of 1.1x and above a fair ratio of 1.4x, which indicates valuation risk if sentiment changes.

For anyone weighing the gap between narrative and sales based pricing, it may be useful to test your own assumptions against potential movements in the P/S ratio over time and consider what that could imply for potential returns.

Next Steps

Given the mixed signals around Lemonade's valuation and growth narrative, it makes sense to look at the underlying data yourself and move quickly while sentiment is still forming. To see what others are optimistic about before you firm up your own view, take a closer look at the 2 key rewards.

Looking for more investment ideas beyond Lemonade?

If Lemonade has you thinking more broadly about where to put fresh capital to work, do not stop at one stock when there are entire sets of ideas already filtered for you.

• Target potential value plays before the crowd notices by scanning 45 high quality undervalued stocks that meet strict quality and pricing criteria.
• Anchor your portfolio with sturdier candidates by reviewing the solid balance sheet and fundamentals stocks screener (48 results) that pair financial resilience with underlying fundamentals.
• Hunt for less followed opportunities by using the screener containing 20 high quality undiscovered gems that pass tough quality filters yet still fly under most radars.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.